DIN 02465663 — SPINRAZA 2.4 MG
SPINRAZA is a solution of Nusinersen marketed by BIOGEN CANADA INC. The full Nusinersen monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02465663
- Brand name
- SPINRAZA
- Active ingredient
- Nusinersen
- Strength
- 2.4 MG
- Dosage form
- SOLUTION
- Route
- INTRATHECAL
- Manufacturer
- BIOGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antisense oligonucleotide (SMN2 splicing modifier)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.